RETRACTED: LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT
A Retraction of the Original Research Article
LOXL2 upregulation in gliomas drives tumorigenicity by activating autophagy to promote TMZ resistance and trigger EMT
By Zhang Q, Yang L, Guan G, Cheng P, Cheng W and Wu A (2020). Front. Oncol. 10:569584. doi: 10.3389/fonc.2020.569584
The journal retracts the 29th October 2020 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors requested retraction due to the image integrity concerns, which was then investigated and conducted in accordance with Frontiers’ policies.
This retraction was approved by the Chief Executive Editor of Frontiers. The authors agreed with the retraction.
Citation: Frontiers Editorial Office (2024) Retraction: LOXL2 upregulation in gliomas drives tumorigenicity by activating autophagy to promote TMZ resistance and trigger EMT. Front. Oncol. 14:1475049. doi: 10.3389/fonc.2024.1475049
Received: 02 August 2024; Accepted: 13 August 2024;
Published: 27 August 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org